GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Loxo Oncology stock price down 0% on Friday
(Updated on Mar 15, 2019)

Buy or Hold candidate since Jan 18, 2019 Gain 0.07% PDF

No changes to the price of Loxo Oncology stock on the last trading day (Friday, 15th Mar 2019). During the last trading day the stock fluctuated 0% from a day low at $234.66 to a day high of $234.66. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 49.19% during the next 3 months and, with a 90% probability hold a price between $316.39 and $449.06 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LOXO Signals & Forecast

The Loxo Oncology stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $234.66 and $234.55. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, February 05, 2019, and so far it has fallen -0.0383%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Loxo Oncology stock

Loxo Oncology finds support from accumulated volume at $232.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $225.26 (-4.01%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 27 days ago.)

Trading Expectations (LOXO) For The Upcoming Trading Day Of Monday 18th

For the upcoming trading day on Monday, 18th we expect Loxo Oncology to open at $234.66, and during the day (based on 14 day Average True Range), to move between $234.15 and $235.17, which gives a possible trading interval of +/-$0.510 (+/-0.22%) up or down from last closing price. If Loxo Oncology takes out the full calculated possible swing range there will be an estimated 0.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $234.71 (0.02%) than the support at $232.65 (0.86%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Loxo Oncology stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Loxo Oncology stock to perform well in the short-term.

Current score: 2.500 Buy Candidate Unchanged

Predicted Opening Price for Loxo Oncology of Monday, March 18, 2019

Fair opening price March 18, 2019 Current price
$234.66 ( 0%) $234.66

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LOXO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 234.66 .
R2 234.66 .
R1 234.66 .
Current price: 234.66
Support S1 234.66 .
S2 234.66 .
S3 234.66 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 234.75 0.0384 %
R2 234.73 0.0298 %
R1 234.71 0.0213 %
Current price 234.66
Support S1 232.65 -0.86%
S2 232.53 -0.91%
S3 232.40 -0.96%

FAQ

What is the symbol for Loxo Oncology Stock and on which exchange is it traded?
The symbol for Loxo Oncology is LOXO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Loxo Oncology Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Loxo Oncology stock to perform well in the short-term.

How to buy Loxo Oncology Stock?
Loxo Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Loxo Oncology Stock.

What's the current price of Loxo Oncology Stock?
As of the end of day on the 2019-03-15, the price of an Loxo Oncology (LOXO) share was $234.66.

What is the 52-week high and low for Loxo Oncology Stock?
The 52-week high for Loxo Oncology Stock is $234.93 and the 52-week low is $108.75.
Click to get the best stock tips daily for free!

About Loxo Oncology

Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined cancers primarily in the United States. The companyÂ’s lead product candidate comprises LOXO-101, an oral and selective inhibitor of tropomyosin receptor kinase (TRK), which is in Phase I clinical trial for the treatment of patients with tumor types, such as lung, head and neck, melanoma, colorectal, sarcoma, and breast cancer. Its... LOXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT